Top-Notch Biotech Catapults To Record High On $2.4 Billion Lilly Buyout – Investor's Business Daily
Business News
- Top-Notch Biotech Catapults To Record High On $2.4 Billion Lilly Buyout Investor’s Business Daily
- Eli Lilly boosts immunology business with $2.4 billion deal for Dice Yahoo Finance
- Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology | Eli Lilly and Company Investors | Eli Lilly and Company
- Lilly bets on IL-17-focused Dice Therapeutics with $2.4B deal FierceBiotech
- PayPal-KKR deal, Alibaba shares fall, Eli Lilly-Dice Therapeutics deal: Trending tickers Yahoo Finance
Source: Business News